About ShangPharma (NYSE:SHP)
ShangPharma Corporation (ShangPharma) is a China-based holding company. The Company is a pharmaceutical and biotechnology research and development (R&D) outsourcing company. It provides a range of high-quality, integrated services across the drug discovery and development process to international and Chinese pharmaceutical and biotechnology companies. Its services consist of discovery chemistry, discovery biology and preclinical development, pharmaceutical development and biologics services. It has a diversified and loyal global customer base. In March 2013, the Company completed the merger contemplated by the previously announced Agreement and Plan of Merger (the Merger Agreement), by and among the Company, ShangPharma Holdings Limited (Holdings), ShangPharma Parent Limited (Parent) and ShangPharma Merger Sub Limited (Merger Sub). As a result of the merger, the Company became a wholly owned subsidiary of Parent.
Industry, Sector and Symbol
Industry Biotechnology & Medical Research
Trailing P/E Ratio0.359375
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
ShangPharma (NYSE:SHP) Frequently Asked Questions
What is ShangPharma's stock symbol?
ShangPharma trades on the New York Stock Exchange (NYSE) under the ticker symbol "SHP."
Who are some of ShangPharma's key competitors?
Some companies that are related to ShangPharma include Qiagen (QGEN), Covance (CVD), Anacor Pharmaceuticals (ANAC), Shire Viropharma (VPHM), WuXi PharmaTech (Cayman) (WX), Genus (GNS), Albany Molecular Research (AMRI), Prosensa (RNA), Puretech Health (PRTC), Protalix Biotherapeutics (PLX), Cellular Dynamics International (ICEL), Horizon Discovery Group (HZD), Palatin Technologies (PTN), Silence Therapeutics (SLN), Bioventix (BVXP), Asterias Biotherapeutics (AST), Tissue Regenix Group (TRX) and Matinas BioPharma (MTNB).
Has ShangPharma been receiving favorable news coverage?
News articles about SHP stock have been trending somewhat positive recently, Accern reports. The research firm scores the sentiment of press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. ShangPharma earned a daily sentiment score of 0.11 on Accern's scale. They also assigned media coverage about the company an impact score of 45.70 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next few days.
How do I buy shares of ShangPharma?
Shares of SHP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is ShangPharma's stock price today?
One share of SHP stock can currently be purchased for approximately $0.12.
How can I contact ShangPharma?
ShangPharma's mailing address is No. 5 Building, 998 Halei Road Zhangjiang Hi-Tech Park, Pudong New Area 201203, SHANGHAI, SHA 201203, China. The company can be reached via phone at +86-21-51320088.
MarketBeat Community Rating for ShangPharma (SHP)MarketBeat's community ratings are surveys of what our community members think about ShangPharma and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
ShangPharma (NYSE:SHP) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
ShangPharma (NYSE:SHP) Earnings History and Estimates Chart
ShangPharma (NYSE SHP) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
ShangPharma (NYSE:SHP) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for ShangPharma (NYSE:SHP)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for ShangPharma (NYSE SHP)
No insider trades for this company have been tracked by MarketBeat.com
ShangPharma (NYSE SHP) News Headlines
ShangPharma (NYSE:SHP) SEC Filings
This page is loading this company's SEC Filings. Please wait...
ShangPharma (NYSE:SHP) Income Statement, Balance Sheet and Cash Flow Statement
ShangPharma (NYSE SHP) Stock Chart for Saturday, March, 24, 2018